תאריך: 08/08/2020 - 05/12/2020
ב 4.8.2020 נפתחה בפייזר תחרות גרנטים גלובלית ADVANCE של מחקרים ביוזמת חוקר בנושא אוסטאוארתריטיס וכאב ע"ר אוסטאוארתריטיס.
מדובר בתחרות המתקיימת זו השנה השלישית בנושא כאב, רק שהשנה יש דגש על אוסטיאוארתריטיס. במסגרת התחרות מוענקים 5 גרנטים בסך כולל של עד מיליון דולר (מקס' 200,000 דולר לפרוייקט אחד).
ההגשה אשר מתבצעת באתר ייעודי אפשרית עד 15.9.2020, ואת כל הפרטים הטכנים הרלוונטים לגבי התחרות ניתן למצוא ב- https://www.advanceresearchawards-chronicpain.com/content/home
חשוב להדגיש כי מדובר בתחרות גלובלית, ולכן קשה להעריך את הסיכויים לזכייה.
אודה אם תוכל לבדוק את האפשרות לפרסם את התחרות באתר האגודה הישראלית לכאב, או בניוזלטר לחברי האגודה (במידה ואתם מוציאים).
אני כמובן זמין לכל שאלה בנושא במייל או בטלפון 050-6512687
תודה רבה,
מתניה, חברת פייזר
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.
I would like to share a new RFP that may be of interest to you. This RFP is focused on supporting independent research initiatives.
If you have any questions about this RFP or the grant application process, please contact my colleague, Jessica Romano at jessica.romano@pfizer.com.
Request for Proposals (RFP)
ADVANCE: Global Awards for Advancing Chronic Pain Research
|
|
|
| (Request for Proposals (RFP
ADVANCE: Global Awards for Advancing Chronic Pain Research |
|
|
|
|
|
| Pfizer Inc. and Eli Lilly and Company are pleased to announce the call for proposals for the third Global Awards for Advancing Chronic Pain Research (ADVANCE), an independently-reviewed competitive grants program. |
|
|
|
|
|
|
Date RFP Issued: August 4, 2020
Geographic Scope: Global
Clinical Area: Chronic Pain
Link to RFP Information: ADVANCE: Global Awards for Advancing Chronic Pain Research
Application Due Date: September 15, 2020
Specific Area of Interest: Areas of research that are considered in-scope for an ADVANCE research grant, with the condition of interest being osteoarthritis (OA) and chronic pain associated with OA, will include studies that aim to advance the understanding of the following.
– Evaluation of unmet medical needs in pain management associated with OA as follows:
· Benefit-risk assessment and patient preference in the choice of pain medication for patients with comorbid conditions (e.g., cardiovascular disease or history of substance abuse)
· How risks associated with long-term use of analgesics are assessed currently
· Treatment of chronic pain in special populations (e.g., postsurgical, elderly)
– Evaluation of multi-disciplinary approaches to management of OA (e.g., physical therapy, cognitive behavioral therapy [CBT]) and their combination with pharmacological treatment
– Understand and predict response to treatment, disease state, and course of OA (normal and rapid trajectories)
– Approaches to improving adherence to therapy or therapeutic regimes for pain associated with OA
– Use of patient characteristics such as biomarkers or other objective evaluations (e.g., quantitative sensory testing [QST], imaging modalities) in the assessment and management of OA to better understand disease course
– Evaluation of improved function
· How changes of physical function are assessed in clinical practice in patients with OA, and how current physical function assessment could be improved
· How individual goal setting can contribute to treatment outcome (including pain and function)
· What impact the improved physical function has on the patients’ quality of life
|
|
|
|
|
|
|
|
